Joseph Foss, M.D.
| Appointed: |
2005 |
| Gender: |
Male |
| Languages: |
English |
General Anesthesiology
Director, Clinical Research for General Anesthesiology
Biographical Sketch
Joseph Foss, MD, is the Director of Clinical Research for General Anesthesiology in the Department of Anesthesiology at Cleveland clinic’s main campus. His specialty interests include clinical research, pain research, and clinical pharmacology, general and ambulatory anesthesia.
Dr. Foss earned his medical degree from Brown University School of Medicine in Providence, R.I. He completed a surgical internship at the University of Oregon Health Sciences Center in Portland, Ore. He also completed an anesthesia residency and a clinical pharmacology fellowship at the University of Chicago Hospitals in Chicago, Ill.
He is a Diplomate with the American Board of Anesthesiology, and a member of several medical societies, including the American Medical Association, the Ohio Society of Anesthesiologists, the American Society of Anesthesiologists and the International Anesthesia Research Society, among others.
Dr. Foss has published a number of articles in peer-reviewed journals on various topics related to anesthesiology and pharmacology. He has also lectured on the topics.
Education & Fellowships
| Medical School: | Brown University School of Medicine, Providence, RI |
|
| Internship: | University of Oregon Health Sciences Center, Transitional, Portland, OH |
| Residency: | University of Chicago Hospitals, Anesthesiology, Chicago, IL |
| Fellowship: | University of Chicago Hospitals, Clinical Pharmacology, Chicago, IL |
| Other Education: | (Undergraduate) Brown University, Providence, RI |
Certifications
Specialty Interests
Clinical pharmacology, clinical research, general and ambulatory anesthesia, general anesthesia, pain research.
Innovations & Patents
Developed a novel drug, methylnaltrexone, which is under FDA review for the treatment of side effects of opioid pain medications.
Professional Memberships
- American Society of Anesthesiologists
- International Anesthesia Research Society
- American Society of Clinical Pharmacology and Therapeutics
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Foss has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Foss receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Eisai Medical Research Inc.
Royalty Payments. Dr. Foss has the right to receive royalty payments for inventions or discoveries related to the companies shown below:
Equity. Dr. Foss owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
- Baxter Healthcare Corporation
- Cardinal Health, Inc.
- Progenics, Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
